Skip to main content
High RiskFDAfda-F-2429-2017UNDECLARED ALLERGEN

Sailors Choice Brand Breaded Clam Strips Pack Size: 24/4 oz. bags/case

Units Affected
1,705
Recall Date
June 7, 2017
Issuing Agency
Hazard
Undeclared Allergen

FDA Recall Notice

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-2429-2017.

Sea Watch International used blended bread coating that is being recalled due the potential presence of undeclared milk. Milk is not declared as an allergen or in an advisory statement on Sea Watch breaded clam strips labels.

Corrective Action (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-2429-2017.

Recall terminated by FDA.

✅ What you should do

  1. Stop using the product if you own it.
  2. Check the model number, lot code, or sell-by date against the recall notice above.
  3. Contact Sea Watch International Ltd or the retailer where you bought it for a refund, replacement, or repair.
  4. For the most current official instructions, visit the FDA recall page.
  5. If you've been hurt by this product, report the incident to FDA.

Consumer Contact (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-2429-2017.

Sea Watch International Ltd

FDA

About the U.S. Food and Drug Administration

The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.

Visit FDA.gov →

📣 Report a food, supplement, or cosmetic problem to the FDA

If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.

How to report to FDAFile a report at FDA

Sea Watch International Ltd Recall FAQ

Sea Watch International Ltd is the subject of a bakery & grains safety report: Sailors Choice Brand Breaded Clam Strips Pack Size: 24/4 oz. bags/case. The notice was published on June 7, 2017 by the U.S. Food and Drug Administration (FDA). Approximately 1,705 units are potentially affected.